ClinConnect ClinConnect Logo
Search / Trial NCT06184971

Biliary Atresia Research Network Northeast

Launched by YALE UNIVERSITY · Dec 13, 2023

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

The Biliary Atresia Research Network Northeast is a clinical trial that is looking at the health records of children with biliary atresia, a serious condition that affects the liver and bile ducts. The goal of the study is to gather information about how children with this condition are managed and what factors lead to better health outcomes. By understanding these factors, researchers hope to improve care for future patients and make better use of healthcare resources.

To participate, children must be 12 years old or younger and have received care related to biliary atresia at one of the hospitals involved in the study between January 1, 2012, and December 31, 2021. This includes those diagnosed with biliary atresia based on specific medical codes. If you know a child who fits this description, they might be eligible to help researchers learn more about this condition. Participants won't need to do anything special, as the study is based on reviewing existing medical records to gather valuable information.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children with a healthcare encounter related to biliary atresia at a participating institution during the study period (January 1st, 2012 through December 31st, 2021)
  • Age 12 years and younger at the time of the qualifying encounter during the study period (encompassing patients born between January 2nd, 1999 through December 31st, 2021)
  • * Diagnosis of biliary atresia, based on one of the following ICD-10 codes:
  • Q44.2 Atresia of bile ducts
  • Q44.3 Congenital stenosis and stricture of bile ducts
  • Q44.4 Disorders of the biliary tract with major complication or comorbidity
  • Q44.5 Other congenital malformations of the bile ducts
  • Q44.6 Disorders of the biliary tract without major complication or comorbidity
  • Exclusion Criteria:
  • Patients aged 13 years old or older during the study period (i.e. those born before January 2nd, 1999)
  • Patients born and/or diagnosed with biliary atresia after the end of the study period (i.e. those born after December 31st, 2021)
  • No diagnosis of biliary atresia
  • History of biliary atresia without any episodes of care related to biliary atresia during the study period (e.g. a teenager with history of BA who underwent Kasai procedure as an infant and has no current issues related to their BA and is receiving care for an unrelated reason)

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

Portland, Maine, United States

Bangor, Maine, United States

Lebanon, New Hampshire, United States

Hartford, Connecticut, United States

Syracuse, New York, United States

New Haven, Connecticut, United States

Boston, Massachusetts, United States

Worcester, Massachusetts, United States

Boston, Massachusetts, United States

Buffalo, New York, United States

Springfield, Massachusetts, United States

Albany, New York, United States

Rochester, New York, United States

Providence, Rhode Island, United States

Patients applied

0 patients applied

Trial Officials

Robert Cowles, MD

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported